Get started
Author

Martin Hendrix

Inhibition of phosphodiesterase 2 increases neuronal cGMP, synaptic plasticity and memory performance
2004 · Frank G. Boess, Martin Hendrix, et al. · Neuropharmacology · 344
New helicase-primase inhibitors as drug candidates for the treatment of herpes simplex disease
2002 · Gerald Kleymann, Rüdiger Fischer, et al. · Nature Medicine · 335
Design and Synthesis of New Aminoglycoside Antibiotics Containing Neamine as an Optimal Core Structure: Correlation of Antibiotic Activity with in Vitro Inhibition of Translation
1999 · William A. Greenberg, E. Scott Priestley, et al. · Journal of the American Chemical Society · 224
Direct Observation of Aminoglycoside−RNA Interactions by Surface Plasmon Resonance
1997 · Martin Hendrix, E. Scott Priestley, et al. · Journal of the American Chemical Society · 206
Probing the Specificity of Aminoglycoside−Ribosomal RNA Interactions with Designed Synthetic Analogs
1998 · Phil B. Alper, Martin Hendrix, et al. · Journal of the American Chemical Society · 193
The novel selective PDE9 inhibitor BAY 73-6691 improves learning and memory in rodents
2008 · F. Josef van der Staay, Kris Rutten, et al. · Neuropharmacology · 179
PDF
Time-dependent involvement of cAMP and cGMP in consolidation of object memory: Studies using selective phosphodiesterase type 2, 4 and 5 inhibitors
2006 · Kris Rutten, Jos Prickaerts, et al. · European Journal of Pharmacology · 178
Specificity of aminoglycoside antibiotics for the A-site of the decoding region of ribosomal RNA
1998 · Chi-Huey Wong, Martin Hendrix, et al. · Chemistry & Biology · 157
PDF
Improving the hit-to-lead process: data-driven assessment of drug-like and lead-like screening hits
2006 · Tobias Wunberg, Martin Hendrix, et al. · Drug Discovery Today · 152
Characterization of the First Potent and Selective PDE9 Inhibitor Using a cGMP Reporter Cell Line
2005 · Frank Wunder, Adrian Tersteegen, et al. · Molecular Pharmacology · 149
The Novel α7 Nicotinic Acetylcholine Receptor Agonist N-[(3 R)-1-Azabicyclo[2.2.2]oct-3-yl]-7-[2-(methoxy)phenyl]-1-benzofuran-2-carboxamide Improves Working and Recognition Memory in Rodents
2007 · Frank G. Boess, Jean De Vry, et al. · Journal of Pharmacology and Experimental Therapeutics · 142
Potent In Vivo Antiviral Activity of the Herpes Simplex Virus Primase-Helicase Inhibitor BAY 57-1293
2002 · Ulrich A. K. Betz, Rüdiger Fischer, et al. · Antimicrobial Agents and Chemotherapy · 134
A Library Approach to the Discovery of Small Molecules That Recognize RNA: Use of a 1,3-Hydroxyamine Motif as Core
1998 · Chi-Huey Wong, Martin Hendrix, et al. · Journal of the American Chemical Society · 113
In Silico ADMET Traffic Lights as a Tool for the Prioritization of HTS Hits
2006 · Mario Lobell, Martin Hendrix, et al. · ChemMedChem · 110
Hydroxyamines as a New Motif for the Molecular Recognition of Phosphodiesters: Implications for Aminogloycoside–RNA Interactions
1997 · Martin Hendrix, Phil B. Alper, et al. · Angewandte Chemie International Edition in English · 88
A convergent synthesis of (+)-pancratistatin based on intramolecular electrophilic aromatic substitution
1997 · Timothy J. Doyle, Martin Hendrix, et al. · Tetrahedron · 64
Pharmacological and behavioral profile of N-[(3R)-1-azabicyclo[2.2.2]oct-3-yl]-6-chinolincarboxamide (EVP-5141), a novel α7 nicotinic acetylcholine receptor agonist/serotonin 5-HT3 receptor antagonist
2012 · Frank G. Boess, Jean de Vry, et al. · Psychopharmacology · 18
A novel approach to amidines from esters
2002 · Heike Gielen, Cristina Alonso-Alija, et al. · Tetrahedron Letters · 18
Hydroxyamine als neues Motiv für die molekulare Erkennung von Phosphodiestern: Hinweise auf Aminoglycosid‐RNA‐Wechselwirkungen
1997 · Martin Hendrix, Phil B. Alper, et al. · Angewandte Chemie · 16
A novel case of cationic rearrangement involving a phenonium ion
1994 · Timothy J. Doyle, Martin Hendrix, et al. · Tetrahedron Letters · 13
A chemoenzymatic approach to carbohydrate-mediated cell adhesion
1996 · Martin Hendrix, C.-H. Wong · Pure and Applied Chemistry · 7
PDF
Selective inhibitors of cGMP phosphodiesterases as procognitive agents
2005 · Martin Hendrix · BMC Pharmacology · 5
Phosphodiesterase Inhibitors: A Chemogenomic View
2004 · Martin Hendrix, Christopher Kallus · Methods and principles in medicinal chemistry · 3
Characterization of the novel PDE9 inhibitor BAY 73-6691 using a cGMP reporter cell line
2005 · Frank Wunder, Adrian Tersteegen, et al. · BMC Pharmacology · 1
PDF
P1‐234: Pharmacological and behavioral profile of EVP‐5141, a novel α7 nicotinic acetylcholine receptor agonist
2009 · Frank Boess, Jean de Vry, et al. · Alzheimer s & Dementia
Works count: 27
Citation count: 2,849
H-index: 18
I10-index: 20
Year
Topic
Type